综合干预对肥胖男性青少年血管生成素样蛋白2和血管内皮功能的影响

姚梦; 唐东辉; 白爽

doi:10.16835/j.cnki.1000-9817.2021.12.031

综合干预对肥胖男性青少年血管生成素样蛋白2和血管内皮功能的影响

doi: 10.16835/j.cnki.1000-9817.2021.12.031

姚梦^{1, 2},
唐东辉^1, ,,
白爽¹

1.
北京师范大学体育与运动学院, 北京 100875
2.
北大附中西三旗学校

基金项目:

国家自然科学基金项目 71874017

国家自然科学基金项目 81472992

详细信息

作者简介:
姚梦(1993-), 女, 河北保定人, 硕士, 中学二级教师, 主要研究方向为体质与健康、青少年体重控制

通讯作者:
唐东辉, E-mail: tdh1964@bnu.edu.cn

中图分类号: R723.14 R446 R179
计量
- 文章访问数: 485
- HTML全文浏览量: 272
- PDF下载量: 25
- 被引次数: 0
出版历程
- 收稿日期: 2021-02-04
- 修回日期: 2021-06-29
- 网络出版日期: 2021-12-23
- 刊出日期: 2021-12-25

Effect of comprehensive intervention on ANGPTL2 and vascular endothelial function in obese male adolescents

YAO Meng^{1, 2},
TANG Donghui^{1
, ,},
BAI Shuang¹

1.
College of P.E. and Sports Science, Beijing Normal University, Beijing (100875), China

摘要

摘要: 目的观察运动结合饮食控制的综合干预方案对肥胖男性青少年血管生成素样蛋白2(angiopoietin-likeprotem 2, ANGPTL2)和血管内皮功能的影响，为运动降低肥胖男性青少年心血管疾病风险提供理论依据。方法选取42名肥胖男性青少年和10名健康男性青少年分别为实验组和对照组，对实验组青少年开展6周运动结合饮食控制的综合干预，测定干预前后身体形态和血压、糖脂代谢、炎症水平和血管内皮功能的变化。结果 6周综合干预后，实验组青少年的体重、体质量指数(BMI)、腰围、腰臀比、收缩压、舒张压指标均降低(P值均 < 0.05)；总胆固醇、三酰甘油、低密度脂蛋白胆固醇血脂水平均降低(P值均 < 0.05)；肿瘤坏死因子α、ANGPTL2炎症水平均降低(P值均 < 0.05)；反应性充血指数(RHI)、一氧化氮/内皮素-1(NO/ET-1)、一氧化氮、动脉粥样硬化指数(AI)血管内皮功能显著改善(P值均 < 0.05)。综合干预前后，肥胖男性青少年的ANGPTL2变化值与体重(r=0.37)、BMI(r=0.45)、RHI(r=-0.46)、NO/ET-1(r=-0.41)、NO(r=-0.45)、AI(r=0.33)的变化值显著相关(P值均 < 0.05)。结论综合干预能有效改善肥胖男性青少年的身体形态、血脂水平和血管内皮功能，降低ANGPTL2水平。ANGPTL2可能参与了综合干预对肥胖男性青少年血管内皮功能的改善过程。
- 肥胖症 /
- 血管生成素2 /
- 心血管系统 /
- 青少年 /
- 男(雄)性
Abstract: Objective To investigate the effect of a comprehensive exercise intervention program combined with diet control on ANGPTL2 and vascular endothelial function in obese male adolescents, and to provide theoretual basis for exercise to reduce the risk of cardiovascular disease in obese male adolescents. Methods Forty-two obese male adolescents and 10 healthy male adolescents were selected, a comprehensive intervention of 6 weeks of exercise combined with diet control was carried out on obese male adolescents, and changes in morphological function, glucose and lipid metabolism, inflammation level and vascular endothelial function were measured before and after the intervention. Results After 6 weeks of comprehensive intervention, the morphological and functional indicators of obese adolescents were significantly reduced: weight, BMI, waist circumference, waist-to-hip ratio, systolic blood pressure, diastolic blood pressure (P < 0.05); blood lipid levels significantly decreased, including TC, TG and LDL-C (P < 0.05); inflammation levels significantly decreased, including TNF-α and ANGPTL2 (P < 0.05); Vascular endothelial function significantly improved: RHI, NO/ET-1, NO, AI(P < 0.05). Before and after 6 weeks of comprehensive intervention, the ANGPTL2 of obese adolescents was significantly correlated with weight (r=0.37), BMI (r=0.45), RHI (r=-0.46), NO/ET-1 (r=-0.41), NO(r=-0.45), and AI (r=0.33)(P < 0.05). Conclusion The comprehensive intervention can effectively improve the morphological function, blood lipid level and vascular endothelial function of obese male adolescents, and reduce the circulating level of ANGPTL2. ANGPTL2 may be involved in the process of comprehensive intervention to improve the vascular endothelial function of obese adolescents.
- Obesity /
- Angiopoietin-2 /
- Cardiovascular system /
- Adolescent /
- Male

HTML全文

表 1 不同组别青少年干预前后身体形态、血压、糖脂代谢、炎症水平及血管内皮功能比较(x±s)

Table 1. Comparison of changes in morphological function, pressure, glucose and lipid metabolism, inflammation level and vascular endothelial function before and after intervention in different groups of adolescents(x±s)

组别	干预前后	统计值	身高/cm	体重/kg	BMI/(kg·m^-2)	腰围/cm	腰臀比	收缩压/mm Hg	舒张压/mm Hg	TC/(mmol·L^-1)	TG/(mmol·L^-1)	LDL-C/(mmol·L^-1)
对照组	干预前		170.52±8.65	61.15±6.99	22.20±1.38	73.2±7.78	0.79±0.04	109.90±7.82	63.91±5.15	3.52±0.34	0.71±0.18	2.19±0.49
(n=10)	干预后		171.43±9.32	61.87±6.78	22.52±1.54	71.93±7.06	0.77±0.06	107.67±6.88	64.62±3.02	3.46±0.28	0.67±0.09	2.16±0.13
		t值	-0.22	-0.23	-0.49	0.38	0.88	0.68	-0.38	0.43	0.63	0.19
		P值	0.82	0.81	0.63	0.70	0.39	0.51	0.70	0.67	0.53	0.85
实验组	干预前		170.89±7.15	102.87±16.29^**	35.27±3.98^**	108.89±9.23^**	0.96±0.04^**	127.33±10.21^**	69.43±8.27^**	4.69±0.59^**	1.70±0.74^**	3.14±0.60^**
(n=42)	干预后		171.05±6.84	90.34±14.74	30.83±3.76	99.96±10.02	0.92±0.07	117.64±11.39	60.74±8.29	3.80±0.54	1.06±0.45	2.32±0.58
		t值	-0.10	3.70	5.26	4.23	3.22	4.10	4.81	7.21
		P值	0.91	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01

组别	干预前后	统计值	HDL-C/(mmol·L^-1)	FPG/(mmol·L^-1)	FINS/(mIU·L^-1)	HOMA-IR	ANGPTL2/(ng·mL^-1)	TNF-α/(pg·mL^-1)	RHI	NO/(μmol·L^-1)	NO/ET-1	AI
对照组	干预前		1.60±0.07	4.28±0.56	8.15±3.34	1.56±0.71	1.25±0.34	20.83±6.28	1.88±0.14	63.31±3.89	3.12±0.89	2.29±0.27
(n=10)	干预后		1.62±0.09	4.22±0.38	8.43±5.12	1.49±0.63	1.27±0.31	20.32±5.78	1.90±0.16	63.67±3.66	3.21±0.77	2.32±0.33
		t值	-0.55	0.28	-0.15	0.17	-0.14	0.19	-0.30	-0.21	-0.24	-0.22
		P值	0.58	0.78	0.88	0.86	0.89	0.85	0.77	0.83	0.81	0.82
实验组	干预前		1.10±0.20^**	4.64±0.46^**	21.16±11.51^**	4.36±2.53^**	3.68±0.62^**	32.79±8.32^**	1.48±0.24^**	44.47±12.76^**	1.69±0.41^**	3.16±0.88^**
(n=42)	干预后		1.08±0.16	4.59±0.38	10.54±5.54	2.19±1.25	3.17±0.57	23.62±10.04	1.77±0.26	58.84±13.56	2.67±0.86	2.67±0.70
		t值	1.23	0.54	5.39	4.98	3.92	4.56	-5.31	-5.00	-6.67	2.82
		P值	0.22	0.58	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01	< 0.01
注：1 mm Hg=0.133 kPa；与干预前对照组相比，**P < 0.01。

下载: 导出CSV

参考文献(16)

[1]	ROBERT H E, SCOTT M G, PAUL Z Z. The metabolic syndrome[J]. Lancet, 2005, 365: 1415-1428. doi: 10.1016/S0140-6736(05)66378-7
[2]	CABALLERO A E. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease[J]. Obes Res, 2003, 11(11): 1278-1289. doi: 10.1038/oby.2003.174
[3]	IANTORNO M, CAMPIA U, DI DANIELE N, et al. Obesity, inflammation and endothelial dysfunction[J]. J Biol Regul Homeost Agents, 2014, 28(2): 169-176.
[4]	GAETANO S. Angiopoietin-like proteins: a comprehensive look[J]. Front Endocrinol, 2014, 5: 4.
[5]	JUNG C H, LEE W J, LEE M J, et al. Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes[J]. Cardiovasc Diabetol, 2015, 14(1): 35. doi: 10.1186/s12933-015-0198-z
[6]	DURÁN W N, BRESLIN J W, SÁNCHEZ F A. The NO cascade, eNOS location, and microvascular permeability[J]. Cardiovasc Res, 2010, 87(2): 254-261. doi: 10.1093/cvr/cvq139
[7]	中国肥胖问题工作组. 中国学龄儿童青少年超重、肥胖筛查体重指数值分类标准[J]. 中华流行病学杂志, 2004, 25(2): 97-102. doi: 10.3760/j.issn:0254-6450.2004.02.003 Group of China Obesity Task Force. Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents[J]. Chin J Epidemiol, 2004, 25(2): 97-102. doi: 10.3760/j.issn:0254-6450.2004.02.003
[8]	唐东辉, 侯玉洁, 白爽, 等. 运动结合饮食控制通过降低RAAS系统活性改善男性肥胖男性青少年血管内皮功能[J]. 体育科学, 2017, 37(9): 48-54. TANG D H, HOU Y J, BAI S, et al. Exercise combined with diet control improving male obese adolescents' vascular endothelial function through reducing the activity of RAAS system[J]. Chin Sport Sci, 2017, 37(9): 48-54.
[9]	XU Y, ARORA R C, HIEBERT B M, et al. Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis[J]. Eur Heart J Cardiovasc Imag, 2014, 15(7): 736-737. doi: 10.1093/ehjci/jet256
[10]	YANO S, TOBITA H, UNO C, et al. Reactive hyperemia index is suitable for screening endothelial dysfunction especially in obese subjects with non-alcoholic hepatitis[J]. Atherosclerosis, 2018, 275: e191-197.
[11]	TANG D H, BAI S, LI X L, et al. Improvement of microvascular endothelial dysfunction induced by exercise and diet is associated with microRNA-126 in obese adolescents[J]. Microvasc Res, 2018, 123: 86-91.
[12]	李娟, 唐东辉, 陈巍. 有氧运动结合抗阻训练对男性肥胖男性青少年心血管功能的改善及可能机制[J]. 体育科学, 2013, 33(8): 37-42. doi: 10.3969/j.issn.1000-677X.2013.08.005 LI J, TANG D H, CHEN W, et al. The Effects of aerobic combined with resistance exercise on cardiovascular efficiency in male obese adolescents and related mechanisms[J]. Chin Sport Sci, 2013, 33(8): 37-42. doi: 10.3969/j.issn.1000-677X.2013.08.005
[13]	ALEXOPOULOS N, KATRITSIS D, RAGGI P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis[J]. Atherosclerosis, 2014, 233(1): 104-112. doi: 10.1016/j.atherosclerosis.2013.12.023
[14]	SASAKI Y, OHTA M, DESAI D, et al. Angiopoietin-likeprotein 2 (ANGPTL2) promotes adipose tissue macrophage and T lymphocyte accumulation and leads to insulin resistance[J]. PLoS One, 2015, 10(7): 35.
[15]	TABATA M, KADOMATSU T, FUKUHARA S, et al. Angiopoietin-likeprotein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance[J]. Cell Metab, 2009, 10(3): 178-188. doi: 10.1016/j.cmet.2009.08.003
[16]	HORIO E, KADOMATSU T, MIYATA K, et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression[J]. Arterioscler Thromb Vasc Biol, 2014, 34(4): 790-800. doi: 10.1161/ATVBAHA.113.303116